Description
Semax is a synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH). Originally developed in Russia, it has been studied for its nootropic and neuroprotective properties, with particular focus on its ability to modulate brain-derived neurotrophic factor (BDNF) and related neurological pathways.
In laboratory research, Semax has been investigated for its potential to enhance cognitive function, protect neuronal cells from damage, and support neuroplasticity. Its effects on the dopaminergic and serotonergic systems, as well as its role in regulating stress response mechanisms, make it a widely studied compound in neuroscience and cognitive research.
Key Research Features:
– Nootropic Research: Studied for its potential effects on memory, focus, and cognitive performance
– BDNF Upregulation: Investigated for its ability to increase brain-derived neurotrophic factor in research models
– Neuroprotection: Explored for protecting neuronal cells from oxidative stress and damage
– Neurotransmitter Modulation: Associated with dopaminergic and serotonergic pathway regulation
– Research-Grade Quality: Intended strictly for laboratory and scientific research purposes only




Reviews
There are no reviews yet.